Item:Q10683: Difference between revisions

Revision as of 18:26, 3 June 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,371 edits ‎Added [en] aliases: 3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate, beta-Nicotinamide adenine dinucleotide trihydrate, beta-NAD, [adenylate-32-P]-NAD, Diphosphopyridine nucleotide oxidized, [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) hydrogen phosphate, Cozymase I, 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-est... ← Older edit	Revision as of 18:26, 3 June 2023 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,371 edits ‎Created claim: instance of (P2): type of chemical entity (Q2546) Newer edit →
	Property / instance of
		type of chemical entity
	Property / instance of: type of chemical entity / rank
		Normal rank